|

Super1 TCR-T Clinical Trials

1 actively recruiting trial

Also known as: NY-ESO-1 TCR-T

Pipeline

Phase 1: 1

Top Sponsors

  • Guangzhou FineImmune Biotechnology Co., LTD.1

Indications

  • Lung Cancers1
  • Sarcoma1
  • Melanoma1
  • Lung Cancer1
  • Cancer1

Other1 trial

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.